• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[具体内容]和[具体内容]的作用及其对COVID-19的遗传易感性。 (你提供的原文不完整,我只能按照格式要求翻译现有内容)

Role of and and their genetic susceptibility to COVID-19.

作者信息

Al-Zahrani Maryam H, Alghamdi Rana A, Tarbiah Nesrin I, Alkhattabi Nuha A, Joharjy Husam M, Khalifa Reham A

机构信息

Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Department of Chemistry, Sciences and Arts College, King Abdulaziz University, Rabigh, Saudi Arabia.

出版信息

Saudi J Biol Sci. 2023 Nov;30(11):103821. doi: 10.1016/j.sjbs.2023.103821. Epub 2023 Sep 27.

DOI:10.1016/j.sjbs.2023.103821
PMID:38020556
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10666556/
Abstract

SARS-CoV-2, which initiated the worldwide COVID-19 epidemic in 2019, has rapidly emerged and spread, resulting in significant public health challenges worldwide. The COVID-19 severity signs and their association with specific genes have been investigated to better comprehend this phenomenon. In this study, several genes were investigated to see whether they correspond with COVID-19 sickness severity. This research aims to determine and evaluate certain gene expression levels associated with the immune system, as these genes were reported to play important roles in immune control during the COVID-19 outbreak. We analyzed two immunity-linked genes: and in COVID-19 patients' samples using RT-PCR, compared them to the samples from recovered, immunized, and healthy individuals. These data were examined to determine the potential relationships between clinical patterns, illness severity, and progression, and SARS-CoV-2 infection immunology. We observed that gene expression was higher in COVID-19 vaccinated and control groups, but lower in active and recovered COVID-19 patients. On the other hand, gene expression was elevated in infected and recovered COVID-19 groups. According to our study, the proteins CD27 and SAMHD1 are essential for controlling the immunological response to COVID-19. Changes in their expression levels could increase the susceptibility of patients to severe complications associated with the disease. Therefore, the gene expression level of these proteins could serve as viable prognostic markers for COVID-19.

摘要

2019年引发全球新冠疫情的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)迅速出现并传播,给全球公共卫生带来了重大挑战。为了更好地理解这一现象,人们对新冠病毒疾病的严重程度体征及其与特定基因的关联进行了研究。在本研究中,对多个基因进行了调查,以确定它们是否与新冠病毒疾病的严重程度相关。这项研究旨在确定和评估与免疫系统相关的某些基因表达水平,因为据报道这些基因在新冠疫情期间的免疫控制中发挥着重要作用。我们使用逆转录聚合酶链反应(RT-PCR)分析了新冠患者样本中的两个与免疫相关的基因,并将其与康复者、接种疫苗者和健康个体的样本进行比较。对这些数据进行了分析,以确定临床模式、疾病严重程度和病程与SARS-CoV-2感染免疫学之间的潜在关系。我们观察到,在接种新冠疫苗的人群和对照组中,某基因的表达较高,但在新冠病毒活跃感染者和康复者中较低。另一方面,在新冠病毒感染组和康复组中,另一基因的表达有所升高。根据我们的研究,CD27和SAMHD1蛋白对于控制新冠病毒的免疫反应至关重要。它们表达水平的变化可能会增加患者发生与该疾病相关的严重并发症的易感性。因此,这些蛋白的基因表达水平可作为新冠病毒疾病可行的预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/10666556/ebc8cb61a901/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/10666556/39b354b63bfd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/10666556/705e2ab1cb22/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/10666556/ebc8cb61a901/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/10666556/39b354b63bfd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/10666556/705e2ab1cb22/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/10666556/ebc8cb61a901/gr3.jpg

相似文献

1
Role of and and their genetic susceptibility to COVID-19.[具体内容]和[具体内容]的作用及其对COVID-19的遗传易感性。 (你提供的原文不完整,我只能按照格式要求翻译现有内容)
Saudi J Biol Sci. 2023 Nov;30(11):103821. doi: 10.1016/j.sjbs.2023.103821. Epub 2023 Sep 27.
2
[Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine].[对感染新冠病毒疾病并接种新冠疫苗的医护人员的新冠病毒特异性体液免疫和细胞免疫值的调查]
Mikrobiyol Bul. 2022 Jul;56(3):480-492. doi: 10.5578/mb.20229708.
3
Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.黏膜基因表达对 SARS-CoV-2 反应与病毒载量相关。
J Virol. 2023 Feb 28;97(2):e0147822. doi: 10.1128/jvi.01478-22. Epub 2023 Jan 19.
4
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.mRNA 疫苗诱导的 T 细胞对 SARS-CoV-2 关切变异株的反应完全相同,但根据先前的感染状态,其持久性和归巢特性存在差异。
Elife. 2021 Oct 12;10:e72619. doi: 10.7554/eLife.72619.
5
Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children.恢复还是持续:儿童新冠病毒感染的免疫病理学特征
J Clin Med. 2022 Jul 27;11(15):4363. doi: 10.3390/jcm11154363.
6
New Presentation of CD27 Deficiency; Coronary Ectasia and COVID-19.CD27缺乏症的新表现;冠状动脉扩张与新型冠状病毒肺炎
Iran J Allergy Asthma Immunol. 2023 Feb 20;22(1):110-118. doi: 10.18502/ijaai.v22i1.12013.
7
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
8
Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.新型冠状病毒感染康复者血清特异性 IgG 抗体持久性及其与临床症状和疾病严重程度的关系:一项前瞻性纵向队列研究。
Int Immunopharmacol. 2021 Sep;98:107893. doi: 10.1016/j.intimp.2021.107893. Epub 2021 Jun 16.
9
Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption.利妥昔单抗治疗中断后多发性硬化症患者对 SARS-CoV-2 mRNA 疫苗接种的免疫反应。
Front Immunol. 2023 Jul 27;14:1219560. doi: 10.3389/fimmu.2023.1219560. eCollection 2023.
10
Vaccination increased host antiviral gene expression and reduced COVID-19 severity during the Omicron variant outbreak in Fuyang City, China.接种疫苗可增加宿主抗病毒基因表达,降低中国阜阳市奥密克戎变异株流行期间 COVID-19 的严重程度。
Int Immunopharmacol. 2023 Jul;120:110333. doi: 10.1016/j.intimp.2023.110333. Epub 2023 May 15.

引用本文的文献

1
Mass Cytometry Analysis of High-Dimensional Single-Cell Immune Profiles in ZF2001-Vaccinated Patients Infected with SARS-CoV-2.对感染SARS-CoV-2的ZF2001疫苗接种患者的高维单细胞免疫图谱进行质谱流式细胞术分析。
Infect Drug Resist. 2025 May 14;18:2497-2509. doi: 10.2147/IDR.S511936. eCollection 2025.

本文引用的文献

1
New Presentation of CD27 Deficiency; Coronary Ectasia and COVID-19.CD27缺乏症的新表现;冠状动脉扩张与新型冠状病毒肺炎
Iran J Allergy Asthma Immunol. 2023 Feb 20;22(1):110-118. doi: 10.18502/ijaai.v22i1.12013.
2
Elimination of Aicardi-Goutières syndrome protein SAMHD1 activates cellular innate immunity and suppresses SARS-CoV-2 replication.SAMHD1 是 Aicardi-Goutières 综合征相关蛋白,其失活可激活细胞固有免疫,抑制 SARS-CoV-2 复制。
J Biol Chem. 2022 Mar;298(3):101635. doi: 10.1016/j.jbc.2022.101635. Epub 2022 Jan 25.
3
Gene Expression Risk Scores for COVID-19 Illness Severity.
新冠病毒疾病严重程度的基因表达风险评分。
J Infect Dis. 2023 Feb 1;227(3):322-331. doi: 10.1093/infdis/jiab568.
4
Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome.无症状 COVID-19 感染中上调的 I 型干扰素反应与改善的临床结局相关。
Sci Rep. 2021 Nov 25;11(1):22958. doi: 10.1038/s41598-021-02489-4.
5
Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.利用美国国家 COVID 队列协作的数据,对美国成年人中 SARS-CoV-2 感染的临床特征和临床严重程度进行临床描述和预测。
JAMA Netw Open. 2021 Jul 1;4(7):e2116901. doi: 10.1001/jamanetworkopen.2021.16901.
6
Immunological predictors of disease severity in patients with COVID-19.新型冠状病毒肺炎患者疾病严重程度的免疫学预测指标
Int J Infect Dis. 2021 Sep;110:83-92. doi: 10.1016/j.ijid.2021.06.056. Epub 2021 Jul 1.
7
A blood RNA transcriptome signature for COVID-19.一种用于新冠肺炎的血液RNA转录组特征
BMC Med Genomics. 2021 Jun 11;14(1):155. doi: 10.1186/s12920-021-01006-w.
8
Primary Care Relevant Risk Factors for Adverse Outcomes in Patients With COVID-19 Infection: A Systematic Review.COVID-19 感染患者不良结局的初级保健相关风险因素:系统评价。
J Am Board Fam Med. 2021 Feb;34(Suppl):S113-S126. doi: 10.3122/jabfm.2021.S1.200429.
9
Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages.通过对支气管肺泡灌洗液的固有和适应性免疫单细胞分析来区分轻症和重症 COVID-19。
Cell Res. 2021 Mar;31(3):272-290. doi: 10.1038/s41422-020-00455-9. Epub 2021 Jan 21.
10
Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes.对具有轻度、中度和重度临床结果的新冠肺炎患者进行宿主转录组分析。
Comput Struct Biotechnol J. 2020 Dec 17;19:153-160. doi: 10.1016/j.csbj.2020.12.016. eCollection 2021.